At Amgen, our health equity efforts are focused on expanding access to clinical trial participation among historically underserved populations, facilitating comprehensive health education, and engaging with community support systems.
Amgen is working to advance policies and practices in support of achieving health equity so that all people have an opportunity to maximize health outcomes.
RISE is an Amgen program dedicated to improving the diversity and representation of participants in the company's clinical trials.
Amgen’s Health Equity Challenge is identifying scalable solutions to address core challenges to improving patient outcomes.
